{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:55:14Z","timestamp":1793037314525,"version":"4.5.0"},"reference-count":68,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001131","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:16:04Z","timestamp":1069366564000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pharmacological interventions for spasticity following spinal cord injury"],"prefix":"10.1002","volume":"2010","author":[{"given":"Mariangela","family":"Taricco","sequence":"first","affiliation":[{"name":"Policlinico Sant'Orsola Malpighi; Unit\u00e0 operativa di Medicina Fisica e Riabilitazione; Via Albertoni 15 Bologna Italy 40138"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Adone","sequence":"additional","affiliation":[{"name":"Ospedale Casati; Servizio di Riabilitazione Funzio (Unita spinale); Via Settembrini, 1 Passirana Di Rho (MI) Italy 20017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pagliacci","sequence":"additional","affiliation":[{"name":"Ospedale Silvestrini; Unit Spinale; Perugia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Telaro","sequence":"additional","affiliation":[{"name":"Mario Negri Institute; Italian Cochrane Centre; Via La Masa 19 Milan Italy 20156"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2000,4,24]]},"reference":[{"key":"10.1002\/14651858.CD001131-BIB0001|cit1","first-page":"131","article-title":"An objective assessment of a gamma aminobutyric acid derivative in the control of spasticity","volume":"8","author":"Burke","year":"1971","journal-title":"Proceedings of the Australian Association of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD001131-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/jnnp.33.4.464","article-title":"A new agent for the control of spasticity","volume":"33","author":"Jones","year":"1970","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001131-BIB0003|cit3","first-page":"19","article-title":"A double blind, cross-over trial of valium in the treatment of spasticity","volume":"10","author":"Corbett","year":"1972","journal-title":"Paraplegia"},{"issue":"10","key":"10.1002\/14651858.CD001131-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.sc.3100481","article-title":"Gabapentin for the treatment of spasticity in patients with spinal cord injury","volume":"35","author":"Gruenthal","year":"1997","journal-title":"Spinal Cord"},{"key":"10.1002\/14651858.CD001131-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/S0317167100042244","article-title":"Intrathecal baclofen for intractable spinal spasticity-a double blind crossover study in eight patients","volume":"19","author":"Hugenholtz","year":"1992","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD001131-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00002060-199202000-00012","article-title":"Intrathecal baclofen. Effects on nocturnal leg muscle spasticity","volume":"71","author":"Kravitz","year":"1992","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/01952307.1994.11735927","article-title":"A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients","volume":"17","author":"Nance","year":"1994","journal-title":"Journal of the American Paraplegia Society"},{"issue":"23","key":"10.1002\/14651858.CD001131-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","article-title":"Intrathecal baclofen for severe spinal spasticity","volume":"320","author":"Penn","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001131-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S0317167100031887","article-title":"Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients","volume":"18","author":"Stewart","year":"1991","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001131-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/jnnp.35.5.599","article-title":"Assessment of cyclobenzaprine in the treatment of spasticity","volume":"35","author":"Ashby","year":"1972","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001131-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0003-9993(96)90217-8","article-title":"Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow up","volume":"77","author":"Azouvi","year":"1996","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD001131-BIB0012|cit12","first-page":"61","article-title":"Dantrolene sodium in the treatment of spasticity","volume":"54","author":"Basmajian","year":"1973","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD001131-BIB0013|cit13","first-page":"223","article-title":"Effects of a GABA-derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study","volume":"53","author":"Basmajian","year":"1974","journal-title":"American Journal of Physical Medicine"},{"key":"10.1002\/14651858.CD001131-BIB0014|cit14","first-page":"403","article-title":"Medication of spasticity with a combination of glycine and folic acid - double blind study]","volume":"33","author":"Bokonjic","year":"1979","journal-title":"Medicinski Arhiv"},{"key":"10.1002\/14651858.CD001131-BIB0015|cit15","first-page":"181","article-title":"Double blind study of progabide in spasticity","volume":"40","author":"Bovier","year":"1985","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD001131-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-7091-9029-6_9","article-title":"Use of intrathecal baclofen administered by programmable infusion pumps in resistant spasticity","volume":"46","author":"Broseta","year":"1989","journal-title":"Acta Neurochirurgica. Supplementum (Wien)"},{"key":"10.1002\/14651858.CD001131-BIB0017|cit17","first-page":"119","article-title":"Balance and Spasticity: what we know and what we believe","volume":"8","author":"Chan","year":"1994","journal-title":"Journal of Neurologic Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0018|cit18","first-page":"393","article-title":"Evaluation of the effect of diazepam on spasticity","volume":"48","author":"Cocchiarella","year":"1967","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0003-9993(94)90337-9","article-title":"Intrathecal baclofen for treatment of intractable spinal spasticity","volume":"75","author":"Abel","year":"1994","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1993.78.2.0226","article-title":"Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study","volume":"78","author":"Coffey","year":"1993","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD001131-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archneur.1980.00500550062008","article-title":"Phenytoin and Chlorpromazine in the treatment of spasticity","volume":"37","author":"Cohan","year":"1980","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD001131-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.sc.3100931","article-title":"Intravenous infusion of 4-AP in chronic spinal cord injured subjects","volume":"38","author":"Donovan","year":"2000","journal-title":"Spinal Cord"},{"key":"10.1002\/14651858.CD001131-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0022-510X(90)90017-H","article-title":"The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects","volume":"100","author":"Fung","year":"1990","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD001131-BIB0024|cit24","first-page":"170","article-title":"A comparison of dantrolene sodium and diazepam in the treatment of spasticity","volume":"12","author":"Glass","year":"1974","journal-title":"Paraplegia"},{"key":"10.1002\/14651858.CD001131-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00002826-199110000-00003","article-title":"L-threonine in the treatment of spasticity","volume":"14","author":"Growdon","year":"1991","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD001131-BIB0026|cit26","first-page":"101","article-title":"A comparative trial of dimethothiazine in spastic conditions","volume":"213","author":"Harvey","year":"1974","journal-title":"The Practitioner"},{"key":"10.1002\/14651858.CD001131-BIB0027|cit27","first-page":"384","article-title":"Dantrolene sodium in children with spasticity","volume":"55","author":"Haslam","year":"1974","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD001131-BIB0029|cit28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00002060-199010000-00006","article-title":"The supraspinal anxiolytic effect of baclofen for spasticity reduction","volume":"69","author":"Hinderer","year":"1990","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0028|cit29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00002060-199012000-00007","article-title":"Spasticity in spinal cord injured persons: quantitative effects of baclofen and placebo treatments","volume":"69","author":"Hinderer","year":"1990","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.4.5778.15","article-title":"Baclofen in the treatment of spasticity","volume":"4","author":"Hudgson","year":"1971","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001131-BIB0031|cit31","first-page":"37","article-title":"Clinical trial of baclofen against placebo","volume":"Suppl 5","author":"Hudgson","year":"1972","journal-title":"Postgraduate Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD001131-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1600-0404.1993.tb05353.x","article-title":"A double-blind study of L-threonine in patients with spinal spasticity","volume":"88","author":"Lee","year":"1993","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD001131-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.18.1_Part_1.69","article-title":"The quantitative evaluation of intravenous methocarbamol in the relief of spasticity","volume":"18","author":"Levine","year":"1968","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001131-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1212\/WNL.19.5.510","article-title":"Prazepam in the treatment of spasticity. A quantitative double-blind evaluation","volume":"19","author":"Levine","year":"1969","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001131-BIB0035|cit35","first-page":"1011","article-title":"Lioresal, a new muscle relaxant in the treatment of spasticity-a double-blind quantitative evaluation","volume":"38","author":"Levine","year":"1977","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD001131-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1469-8749.1966.tb01839.x","article-title":"Chlorzoxazone (paraflex) in the treatment of severe spasticity","volume":"8","author":"Losin","year":"1966","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1002\/14651858.CD001131-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0404.1985.tb03187.x","article-title":"Effect of clorazeprate in spasticity and rigidity: a quantitative study of reflexes and plasma concentrations","volume":"71","author":"Lossius","year":"1985","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD001131-BIB0038|cit38","first-page":"1","article-title":"Delta-9-tetahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial","volume":"240","author":"Maurer","year":"1990","journal-title":"European Archives of Psychiatry and Neurological Sciences"},{"key":"10.1002\/14651858.CD001131-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.63.2.204","article-title":"Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity","volume":"63","author":"Middel","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001131-BIB0041|cit40","first-page":"373","article-title":"Spasticity and the effect of dantrolene sodium","volume":"55","author":"Monster","year":"1974","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0040|cit41","first-page":"163","article-title":"Cooperative study for assessing the effects of a pharmacological agent on spasticity","volume":"52","author":"Monster","year":"1973","journal-title":"American Journal of Physical Medicine"},{"key":"10.1002\/14651858.CD001131-BIB0042|cit42","first-page":"296","article-title":"Reflex changes induced by clonidine in spinal cord injured patients","volume":"27","author":"Nance","year":"1989","journal-title":"Paraplegia"},{"key":"10.1002\/14651858.CD001131-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/01952307.1994.11735927","article-title":"A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients","volume":"17","author":"Nance","year":"1994","journal-title":"Journal of the American Paraplegia Society"},{"key":"10.1002\/14651858.CD001131-BIB0044|cit44","first-page":"A329","article-title":"A randomised double blind placebo controlled study to evaluate the use of botulinum toxin type A in the treatment of spasticity","volume":"45 Suppl 4","author":"O'Brien","year":"1995","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001131-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3171\/jns.1996.85.3.0452","article-title":"Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity","volume":"85","author":"Ordia","year":"1996","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD001131-BIB0046|cit46","first-page":"27","article-title":"Comparative study of tizanidine and baclofen in patients with chronic spasticity","volume":"15","author":"Pagano","year":"1990","journal-title":"Revista Neurologia Argentina"},{"key":"10.1002\/14651858.CD001131-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0003-9993(21)01642-7","article-title":"Functional outcomes after delivery of intrathecal baclofen","volume":"70","author":"Parke","year":"1989","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0404.1970.tb05791.x","article-title":"Gaba derivative in spasticity (Beta-(4-chlorophenyl)-gamma-aminobutyric acid, Ciba 34.647-Ba)","volume":"46","author":"Pedersen","year":"1970","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD001131-BIB0049|cit49","first-page":"216","article-title":"Chronic intrathecal baclofen in severely disabling spasticity: selection, clinical assessment and long-term benefit","volume":"95","author":"Pirotte","year":"1995","journal-title":"Acta Neurologica Belgica"},{"issue":"4","key":"10.1002\/14651858.CD001131-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00019053-199915040-00007","article-title":"Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system","volume":"15","author":"Postma","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1002\/14651858.CD001131-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.sc.3100366","article-title":"Effectiveness of gabapentin in controlling spasticity: a quantitative study","volume":"35","author":"Priebe","year":"1997","journal-title":"Spinal Cord"},{"issue":"4","key":"10.1002\/14651858.CD001131-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp.69.4.499","article-title":"Evaluating the role of botulinum toxin in the management of focal hypertonia in adults","volume":"69","author":"Richardson","year":"2000","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001131-BIB0053|cit53","first-page":"278","article-title":"Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy","volume":"4","author":"Roussan","year":"1985","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD001131-BIB0054|cit54","first-page":"403","article-title":"Comparison of dantrolene sodium and diazepam in the treatment of spasticity","volume":"33","author":"Schmidt","year":"1976","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001131-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1592\/phco.19.9.713.31540","article-title":"Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial","volume":"19","author":"Segal","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD001131-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jnnp.53.9.754","article-title":"The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries","volume":"53","author":"Wainberg","year":"1990","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001131-BIB0057|cit57","first-page":"123","article-title":"Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease","volume":"221","author":"Weiser","year":"1978","journal-title":"Practitioner"},{"key":"10.1002\/14651858.CD001131-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/003693306601100202","article-title":"Oral diazepam in the treatment of spasticity in paraplegia a double-blind trial and subsequent impressions","volume":"11","author":"Wilson","year":"1966","journal-title":"Scottish Medical Journal"},{"key":"10.1002\/14651858.CD001131-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Physical Therapy"},{"issue":"7303","key":"10.1002\/14651858.CD001131-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.323.7303.13","article-title":"Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review","volume":"323","author":"Campbell","year":"2001","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD001131-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02766064","article-title":"Intrathecal baclofen for severe spasticity: a meta-analysis","volume":"3","author":"Creedon","year":"1997","journal-title":"International Journal of Rehabilitation and Health"},{"key":"10.1002\/14651858.CD001131-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD001131-BIB0063|cit63","first-page":"144","article-title":"Spastic hypertonia: mechanisms and measurement","volume":"70","author":"Katz","year":"1989","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0064|cit64","first-page":"566","article-title":"Epidemiology of spasticity following traumatic spinal cord injury","volume":"71","author":"Maynard","year":"1990","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"6","key":"10.1002\/14651858.CD001131-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00002060-200011000-00009","article-title":"Secondary impairments after spinal cord injury. A population-based study","volume":"79","author":"Noreau","year":"2000","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0003-9993(96)90014-3","article-title":"Clinical assessment of spasticity in spinal cord injury: a multidimensional problem","volume":"77","author":"Priebe","year":"1996","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD001131-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schultz","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD001131-BIB0068|cit68","first-page":"53","article-title":"A database of self-reported secondary medical problems among VA SCI patients: its role in clinical care and management","volume":"39","author":"Walter","year":"2002","journal-title":"Journal of Rehabilitation Research and Development"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001131\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:06:49Z","timestamp":1792368409000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001131"}},"subtitle":[],"editor":[{"name":"Cochrane Injuries Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2000,4,24]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001131","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,24]]}}}